Stock CYTH CYCLO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Cyclo Therapeutics, Inc.

Equities

CYTH

US23254X2018

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-03 pm EDT 		5-day change 1st Jan Change
1.51 USD +2.72% Intraday chart for Cyclo Therapeutics, Inc. +19.84% -5.03%
May. 01 HC Wainwright Starts Cyclo Therapeutics With Buy Rating, $3 Price Target MT
Mar. 18 Cyclo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Starts Cyclo Therapeutics With Buy Rating, $3 Price Target
MT
Maxim Upgrades Cyclo Therapeutics to Buy From Hold With $4 Price Target
MT
Maxim Group Downgrades Cyclo Therapeutics to Hold From Buy
MT
Maxim Group Adjusts Cyclo Therapeutics Price Target to $10 From $16, Maintains Buy Rating
MT
CYCLO THERAPEUTICS : Maxim Group Starts Cyclo Therapeutics at Buy With $12 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CYTH Stock
  4. News Cyclo Therapeutics, Inc.
  5. Analyst Reco.